Why We Care

Approximately 20.8 million people (7% of the population) have been diagnosed with diabetes in the U.S. With an increase in obesity rates, many more individuals are at risk for developing Type II diabetes.

Diabetes is a disease process that affects all major organ systems in the body. Uncontrolled blood sugars can damage blood vessels and nerves. Patients with Type II diabetes have twice the risk of developing liver disease and renal failure. Heart disease is the most common cause of death in diabetic adults.

dgd Research strongly believes that, when diabetes is managed through intensive medical interventions utilizing the most effective treatments, the complications and hospitalizations associated with diabetes can be significantly reduced or eliminated. Conducting pharmaceutical clinical trials provides dgd Research access to the most current therapies for treating endocrine and metabolic disorders.